- Home
- KYMR vs TDS Comparison
KYMR vs TDS Comparison
Compare KYMR & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- TDS
- Stock Information
- Founded
- KYMR 2015
- TDS 1968
- Country
- KYMR United States
- TDS United States
- Employees
- KYMR N/A
- TDS N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- TDS Telecommunications Equipment
- Sector
- KYMR Health Care
- TDS Telecommunications
- Exchange
- KYMR Nasdaq
- TDS Nasdaq
- Market Cap
- KYMR 4.7B
- TDS 4.5B
- IPO Year
- KYMR 2020
- TDS N/A
- Fundamental
- Price
- KYMR $67.94
- TDS $40.09
- Analyst Decision
- KYMR Strong Buy
- TDS Buy
- Analyst Count
- KYMR 19
- TDS 2
- Target Price
- KYMR $68.95
- TDS $52.00
- AVG Volume (30 Days)
- KYMR 696.1K
- TDS 848.5K
- Earning Date
- KYMR 11-04-2025
- TDS 11-07-2025
- Dividend Yield
- KYMR N/A
- TDS 0.41%
- EPS Growth
- KYMR N/A
- TDS N/A
- EPS
- KYMR N/A
- TDS N/A
- Revenue
- KYMR $43,735,000.00
- TDS $4,859,865,000.00
- Revenue This Year
- KYMR $60.88
- TDS N/A
- Revenue Next Year
- KYMR N/A
- TDS $0.29
- P/E Ratio
- KYMR N/A
- TDS N/A
- Revenue Growth
- KYMR N/A
- TDS 110.05
- 52 Week Low
- KYMR $19.45
- TDS $31.07
- 52 Week High
- KYMR $68.80
- TDS $42.74
- Technical
- Relative Strength Index (RSI)
- KYMR 68.81
- TDS 60.39
- Support Level
- KYMR $63.86
- TDS $37.60
- Resistance Level
- KYMR $68.80
- TDS $38.70
- Average True Range (ATR)
- KYMR 3.52
- TDS 1.29
- MACD
- KYMR 0.19
- TDS 0.12
- Stochastic Oscillator
- KYMR 94.07
- TDS 95.90
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.